Download PDF
CC BY-NC-ND 4.0 · Ann Natl Acad Med Sci 2016; 52(02): 109-123
DOI: 10.1055/s-0040-1712611
Original Article

Modern concept of Benign Breast Disorders and its Endocrinological Background

Sandeep Kumar
Consultant Surgeon, Scientist & Epidemiologist Professor of Surgery Ex, King George's Medical University Founder Director AIIMS Bhopal HIG 111, Sector E, Aliganj, Lucknow.
› Author Affiliations
› Further Information
Also available at
  PDF Download Permissions and Reprints

ABSTRACT

Mastalgia and generalised breast nodularity where a discrete lump cannot be felt called Aberration of Normal Development and Involution (ANDI) is the most common condition leading to breast related consultations. The author's work on this clinical syndrome over the last 3 decades has led to documentation of its natural history, epidemiological study of ANDI, development of objective scales for clinical assessment of breast pain and nodularity, its endocrinological aetiopathogenesis, response prediction of treatment in cyclical mastalgia, a randomized controlled trial of an indigenous selective estrogen response modulator – ormeloxifene and finally a meta-analysis of treatment for this condition. This turned a full wheel bridging gaps in the knowledge of this disorder and led us to evolve an effective, inexpensive treatment of mastalgia with least side effect. The work is dedicated to Professors LE Hughes, Robert E Mansel and Anurag Srivastava.

COL. SANGHAM LAL MEMORIAL ORATION delivered during NAMSCON 2015 at the All-India Institute of Medical Sciences, Patna.




Publication History

Article published online:
10 May 2020

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • REFERENCES

  • 1 Foote FW, Stewart FW (1945). Comparative studies of cancerous versus non-cancerous breasts. Ann Surg 6 : 121.
  • 2 Love SM, Gelman RS, Silen W (1982). Fibrocystic disease of the breast – A non-disease. New Eng J Med 307 : 1010-1014.
  • 3 CDC JEV fact sheet — /http://www.cdc.gov/ncidod/dvbid/ jencephalitis/facts.htm.Hughes LE (1989). Benign Breast Disorders – Introduction . Fibrocystic Disease ? Nondisease ? or ANDI ? World J Surg 13 : 667- 668.
  • 4 Wisbey JR, Kumar S, Mansel RE, Preece PE, Pye JK, Hughes LE (1983). Natural history of breast pain. Lancet ii: 672-674.
  • 5 Shukla HS, Kumar S (1989). Benign Breast Disorders in Nonwestern Populations: Part II Benign Breast Disorders in India. World J Surg 13: 747.
  • 6 Kumar S, Rai R, Das V, Dwivedi V, Kumar S, Agrawal GG (2010). Vi s u a l a n a l o g u e s c a l e f o r assessing breast nodularity in non discrete lumpy breasts: The L u c k n o w C a r d i f f b r e a s t nodularity scale. The Breast 19 : 238 – 242.
  • 7 Mansel RE, Preece PE, Hughes LE (1978). A double blind trial of t h e p r o l a c t i n i n h i b i t o r bromocriptine in painful benign breast disease. Br J Surg 65: 724.
  • 8 Kumar S, Mansel RE, Jasani B (1987). Presence and possible s i g n i fi c a n c e o f i m m u n o h i s t o c h e m i c a l l y demonstrable prolactin in breast apocrine metaplasia. Br J Cancer 55: 307-309.
  • 9 Kumar S, Mansel RE, Hughes LE, et al. (1984). Prolactin response to Thyrotropin - Releasing H o r m o n e s t i m u l a t i o n a n d dopaminergic inhibition in benign b r e a s t d i s e a s e . Cancer 53:1311-1315.
  • 10 Kumar S, Mansel RE, Hughes LE (1983). Secretory response of prolactin and TSH in benign breast disease before and after TRH stimulation. Br J Surg (abstract) 70: 293..
  • 11 Kumar S, Mansel RE, Scanlon MF, et al. (1984). Altered responses of prolactin, luteinizing hormone and follicle stimulating hormone secretion to thyrotropin r e l e a s i n g h o r m o n e / gonadotrophin releasing hormone stimulation in cyclical mastalgia. Br J Surg 71:870-873.
  • 12 Kumar S, Mansel RE, Read GF, Truran PL, Wilson DW, Hughes L E ( 1 9 8 6 ) . D a i l y s a l i v a r y progesterone levels in cyclical mastalgia patients and their controls. Br J Surg 73: 260 – 263.
  • 13 Kumar S, Mansel RE, Hughes LE, Edwards CA, Scanlon MF (1985). P r e d i c t i o n o f r e s p o n s e t o endocrine therapy in pronounced cyclical mastalgia using dynamic tests of Prolactin release. Clin Endocrinal (Oxford) 23: 699-704.
  • 14 Agarwal PK, Tandon S, Agarwal AK, Kumar S (1989). Highly specific sites of Prolactin binding in benign and malignant breast tissue. Ind J Exp Biol 27: 1035-1038.
  • 15 Rai R, Shrivastava A, Godbole MM, et al. (2011). Human Sodium Iodide Symporter (hNIS) in Fibroadenoma Breast-an Immunohistochemical Study. Ind J of Exp Biol 49(2) : 113 -117.
  • 16 Kataria K, Dhar A, Srivastava A, Kumar S, Goyal A (2013). A Systematic Review of Current Understanding and Management of Mastalgia. Indian J Surg 75: 1- 6.
  • 17 Kumar S, Rai R, Agarwal GG, Dwivedi V, Kumar S, Das V (2013). A Randomised Double Blind Placebo Controlled Clinical T r i a l o f C e n t c h r o m a n (Ormeloxifene) in Breast Pain and Nodularity (Benign Breast Disorder). Nat Med J India 26:69- 74.